221 related articles for article (PubMed ID: 30618189)
1. Angiotensin II receptor blockers are safe in patients with prior angioedema related to angiotensin-converting enzyme inhibitors - a nationwide registry-based cohort study.
Rasmussen ER; Pottegård A; Bygum A; von Buchwald C; Homøe P; Hallas J
J Intern Med; 2019 May; 285(5):553-561. PubMed ID: 30618189
[TBL] [Abstract][Full Text] [Related]
2. Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink.
Mahmoudpour SH; Baranova EV; Souverein PC; Asselbergs FW; de Boer A; Maitland-van der Zee AH;
Br J Clin Pharmacol; 2016 Dec; 82(6):1647-1659. PubMed ID: 27524468
[TBL] [Abstract][Full Text] [Related]
3. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive drug associated angioedema: effect modification by race/ethnicity.
Reichman ME; Wernecke M; Graham DJ; Liao J; Yap J; Chillarige Y; Southworth MR; Keeton S; Goulding MR; Mott K; Kelman JA
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1190-1196. PubMed ID: 28722207
[TBL] [Abstract][Full Text] [Related]
5. Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.
Sørensen GV; Ganz PA; Cole SW; Pedersen LA; Sørensen HT; Cronin-Fenton DP; Garne JP; Christiansen PM; Lash TL; Ahern TP
J Clin Oncol; 2013 Jun; 31(18):2265-72. PubMed ID: 23650417
[TBL] [Abstract][Full Text] [Related]
6. Angioedema induced by angiotensin-converting enzyme inhibitors.
Campo P; Fernandez TD; Canto G; Mayorga C
Curr Opin Allergy Clin Immunol; 2013 Aug; 13(4):337-44. PubMed ID: 23743513
[TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
Lee J; Lee S
Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
[TBL] [Abstract][Full Text] [Related]
8. Angioedema related to Angiotensin inhibitors.
Knecht SE; Dunn SP; Macaulay TE
J Pharm Pract; 2014 Oct; 27(5):461-5. PubMed ID: 25124378
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment.
Rasmussen ER; Hallberg P; Baranova EV; Eriksson N; Karawajczyk M; Johansson C; Cavalli M; Maroteau C; Veluchamy A; Islander G; Hugosson S; Terreehorst I; Asselbergs FW; Norling P; Johansson HE; Kohnke H; Syvänen AC; Siddiqui MK; Lang CC; Magnusson PKE; Yue QY; Wadelius C; von Buchwald C; Bygum A; Alfirevic A; Maitland-van der Zee AH; Palmer CNA; Wadelius M
Pharmacogenomics J; 2020 Dec; 20(6):770-783. PubMed ID: 32080354
[TBL] [Abstract][Full Text] [Related]
10. The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema.
Beavers CJ; Dunn SP; Macaulay TE
Ann Pharmacother; 2011 Apr; 45(4):520-4. PubMed ID: 21427294
[TBL] [Abstract][Full Text] [Related]
11. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema.
Warner KK; Visconti JA; Tschampel MM
Ann Pharmacother; 2000 Apr; 34(4):526-8. PubMed ID: 10772441
[TBL] [Abstract][Full Text] [Related]
13. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
Gilstrap LG; Fonarow GC; Desai AS; Liang L; Matsouaka R; DeVore AD; Smith EE; Heidenreich P; Hernandez AF; Yancy CW; Bhatt DL
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28189999
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers or both in incident end-stage renal disease patients without cardiovascular disease: a propensity-matched longitudinal cohort study.
Ferreira JP; Couchoud C; Gregson J; Tiple A; Glowacki F; London G; Agarwal R; Rossignol P
Nephrol Dial Transplant; 2019 Jul; 34(7):1216-1222. PubMed ID: 30590716
[TBL] [Abstract][Full Text] [Related]
15. End-stage renal disease patients using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may reduce the risk of mortality: a Taiwanese Nationwide cohort study.
Lee HF; See LC; Chan YH; Yeh YH; Wu LS; Liu JR; Tu HT; Wang CL; Kuo CT; Chang SH
Intern Med J; 2018 Sep; 48(9):1123-1132. PubMed ID: 29808610
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitor-induced angioedema: A review of the literature.
Brown T; Gonzalez J; Monteleone C
J Clin Hypertens (Greenwich); 2017 Dec; 19(12):1377-1382. PubMed ID: 28994183
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry.
Song PS; Seol SH; Seo GW; Kim DK; Kim KH; Yang JH; Hahn JY; Gwon HC; Ahn Y; Jeong MH; Song YB; Kim DI;
Am J Cardiovasc Drugs; 2015 Dec; 15(6):439-49. PubMed ID: 26153396
[TBL] [Abstract][Full Text] [Related]
18. Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study.
Shen JI; Saxena AB; Vangala S; Dhaliwal SK; Winkelmayer WC
BMC Nephrol; 2017 Jun; 18(1):196. PubMed ID: 28623899
[TBL] [Abstract][Full Text] [Related]
19. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
Wu LS; Chang SH; Chang GJ; Liu JR; Chan YH; Lee HF; Wen MS; Chen WJ; Yeh YH; Kuo CT; See LC
Cardiovasc Diabetol; 2016 Apr; 15():56. PubMed ID: 27039185
[TBL] [Abstract][Full Text] [Related]
20. Fresh frozen plasma for progressive and refractory angiotensin-converting enzyme inhibitor-induced angioedema.
Hassen GW; Kalantari H; Parraga M; Chirurgi R; Meletiche C; Chan C; Ciarlo J; Gazi F; Lobaito C; Tadayon S; Yemane S; Velez C
J Emerg Med; 2013 Apr; 44(4):764-72. PubMed ID: 23114109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]